Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
COMPASS Pathways plc (CMPS) is a leading other business based in the US. It opened the day at USD$53.49 after a previous close of USD$54.3. During the day the price has varied from a low of USD$53.1082 to a high of USD$58.88. The latest price was USD$57.85 (25 minute delay). COMPASS Pathways is listed on the NASDAQ and employs 0 staff. All prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Mobile users
Open | USD$53.49 |
---|---|
High | USD$58.88 |
Low | USD$53.1082 |
Close | USD$57.85 |
Previous close | USD$54.3 |
Change | USD$3.55 |
Change % | 6.538% |
Volume | 422,489 |
52-week range | USD$22.51 - USD$47.29 |
---|---|
50-day moving average | USD$37.071 |
200-day moving average | USD$37.071 |
Wall St. target price | USD$65 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | N/A |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $57.85 from 2020-10-19
1 week (2021-01-11) | 31.00% |
---|---|
1 month (2020-12-18) | 1.51% |
3 months (2020-10-16) | 48.98% |
6 months (2020-07-14) | N/A |
1 year (2020-01-14) | N/A |
---|---|
2 years (2019-01-14) | N/A |
3 years (2018-01-14) | N/A |
5 years (2016-01-14) | N/A |
Gross profit TTM | USD$0 |
---|---|
Return on assets TTM | 0% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | N/A |
Market capitalisation | USD$1.4 billion |
TTM: trailing 12 months
There are currently 373,699 COMPASS Pathways shares held short by investors – that's known as COMPASS Pathways's "short interest". This figure is up from 0 last month.
There are a few different ways that this level of interest in shorting COMPASS Pathways shares can be evaluated.
COMPASS Pathways's "short interest ratio" (SIR) is the quantity of COMPASS Pathways shares currently shorted divided by the average quantity of COMPASS Pathways shares traded daily (recently around 1.2 million). COMPASS Pathways's SIR currently stands at 0.32. In other words for every 100,000 COMPASS Pathways shares traded daily on the market, roughly 320 shares are currently held short.
To gain some more context, you can compare COMPASS Pathways's short interest ratio against those of similar companies.
However COMPASS Pathways's short interest can also be evaluated against the total number of COMPASS Pathways shares, or, against the total number of tradable COMPASS Pathways shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against COMPASS Pathways.
Find out more about how you can short COMPASS Pathways stock.
We're not expecting COMPASS Pathways to pay a dividend over the next 12 months.
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.